CY1730A - Topical compositions comprising 11,28-dioxa-4-azatricyclo(22.3.1.0(4,9)) octacos-18-ene derivatives - Google Patents
Topical compositions comprising 11,28-dioxa-4-azatricyclo(22.3.1.0(4,9)) octacos-18-ene derivativesInfo
- Publication number
- CY1730A CY1730A CY173094A CY173094A CY1730A CY 1730 A CY1730 A CY 1730A CY 173094 A CY173094 A CY 173094A CY 173094 A CY173094 A CY 173094A CY 1730 A CY1730 A CY 1730A
- Authority
- CY
- Cyprus
- Prior art keywords
- octacos
- azatricyclo
- dioxa
- topical compositions
- ene derivatives
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/436—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having oxygen as a ring hetero atom, e.g. rapamycin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Dermatology (AREA)
- Pulmonology (AREA)
- Immunology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AT0295287A AT400808B (de) | 1987-11-09 | 1987-11-09 | Verwendung von tricyclischen verbindungen zur herstellung von topischen arzneimitteln |
DE3742805 | 1987-12-17 |
Publications (1)
Publication Number | Publication Date |
---|---|
CY1730A true CY1730A (en) | 1994-05-06 |
Family
ID=25599336
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CY173094A CY1730A (en) | 1987-11-09 | 1994-05-06 | Topical compositions comprising 11,28-dioxa-4-azatricyclo(22.3.1.0(4,9)) octacos-18-ene derivatives |
Country Status (13)
Country | Link |
---|---|
US (1) | US20050059694A1 (sv) |
EP (2) | EP0596541B1 (sv) |
JP (1) | JP2604834B2 (sv) |
KR (1) | KR0133916B1 (sv) |
AU (1) | AU619772B2 (sv) |
CH (1) | CH677448A5 (sv) |
CY (1) | CY1730A (sv) |
DK (1) | DK175235B1 (sv) |
GB (1) | GB2212061B (sv) |
HK (1) | HK8694A (sv) |
NL (1) | NL195077C (sv) |
PH (1) | PH26083A (sv) |
SE (2) | SE503236C2 (sv) |
Families Citing this family (39)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4894366A (en) | 1984-12-03 | 1990-01-16 | Fujisawa Pharmaceutical Company, Ltd. | Tricyclo compounds, a process for their production and a pharmaceutical composition containing the same |
IE64214B1 (en) * | 1989-06-06 | 1995-07-26 | Fujisawa Pharmaceutical Co | Macrolides for the treatment of reversible obstructive airways diseases |
US5519049A (en) * | 1989-06-06 | 1996-05-21 | Fisons Plc | Macrolides for the treatment of reversible obstructive airways diseases |
DK0406791T3 (da) * | 1989-07-05 | 1995-03-27 | Fujisawa Pharmaceutical Co | Vandigt flydende præparat til ekstern anvendelse |
KR0159766B1 (ko) * | 1989-10-16 | 1998-12-01 | 후지사와 토모키치로 | 양모제 조성물 |
US5215995A (en) * | 1989-10-16 | 1993-06-01 | Fujisawa Pharmaceutical Co., Ltd. | Hair revitalizing agent |
US5208228A (en) * | 1989-11-13 | 1993-05-04 | Merck & Co., Inc. | Aminomacrolides and derivatives having immunosuppressive activity |
GB8925797D0 (en) * | 1989-11-15 | 1990-01-04 | Fisons Plc | Compositions |
KR0177158B1 (ko) * | 1990-03-01 | 1999-03-20 | 후지사와 도모기찌로 | 면역억제 활성을 갖는 트리사이클릭 화합물 함유 용액 제제 |
US5064835A (en) * | 1990-03-01 | 1991-11-12 | Merck & Co., Inc. | Hydroxymacrolide derivatives having immunosuppressive activity |
JPH05504956A (ja) * | 1990-03-12 | 1993-07-29 | 藤沢薬品工業株式会社 | トリシクロ化合物 |
EP0455427A1 (en) * | 1990-04-30 | 1991-11-06 | Merck & Co. Inc. | Deoxymacrolide derivatives having immunosuppressive activity |
US5342935A (en) * | 1990-06-25 | 1994-08-30 | Merck & Co., Inc. | Antagonists of immunosuppressive macrolides |
US5190950A (en) * | 1990-06-25 | 1993-03-02 | Merck & Co., Inc. | Antagonists of immunosuppressive macrolides |
DE69125230T2 (de) * | 1990-09-04 | 1997-07-10 | Fujisawa Pharmaceutical Co | Tricyclische Verbindungen enthaltende Salben |
GB2248184A (en) * | 1990-09-28 | 1992-04-01 | Fujisawa Pharmaceutical Co | New use of macrolide compounds for active oxygen-mediated diseases |
US5143918A (en) * | 1990-10-11 | 1992-09-01 | Merck & Co., Inc. | Halomacrolides and derivatives having immunosuppressive activity |
US5348966A (en) * | 1990-10-24 | 1994-09-20 | Fujisawa Pharmaceutical Co., Ltd. | Method for treating pyoderma and Sezary's syndrome using FK 506 and related compounds |
PH31204A (en) * | 1990-11-02 | 1998-05-05 | Fujisawa Pharmaceutical Co | Pharmaceutical composition. |
US5147877A (en) * | 1991-04-18 | 1992-09-15 | Merck & Co. Inc. | Semi-synthetic immunosuppressive macrolides |
US5565560A (en) * | 1991-05-13 | 1996-10-15 | Merck & Co., Inc. | O-Aryl,O-alkyl,O-alkenyl and O-alkynylmacrolides having immunosuppressive activity |
US5250678A (en) | 1991-05-13 | 1993-10-05 | Merck & Co., Inc. | O-aryl, O-alkyl, O-alkenyl and O-alkynylmacrolides having immunosuppressive activity |
US5162334A (en) * | 1991-05-13 | 1992-11-10 | Merck & Co., Inc. | Amino O-alkyl, O-alkenyl and O-alkynlmacrolides having immunosuppressive activity |
US5189042A (en) * | 1991-08-22 | 1993-02-23 | Merck & Co. Inc. | Fluoromacrolides having immunosuppressive activity |
US5208241A (en) * | 1991-09-09 | 1993-05-04 | Merck & Co., Inc. | N-heteroaryl, n-alkylheteroaryl, n-alkenylheteroaryl and n-alkynylheteroarylmacrolides having immunosuppressive activity |
ZA926812B (en) | 1991-09-09 | 1993-04-28 | Merck & Co Inc | O-heteroaryl,o-alkylheteroaryl,o-alkenylheteroaryl and o-alkynylheteroaryl macrolides having immunosupressive activity |
US5286731A (en) * | 1991-09-17 | 1994-02-15 | American Home Products Corporation | Method of treating immunoinflammatory bowel disease |
US5286730A (en) * | 1991-09-17 | 1994-02-15 | American Home Products Corporation | Method of treating immunoinflammatory disease |
GB9218597D0 (en) * | 1992-08-25 | 1992-10-14 | Fisons Plc | Novel method of treatment |
MY110603A (en) * | 1993-05-27 | 1998-08-29 | Novartis Ag | Tetrahydropyran derivatives |
JPH06345646A (ja) * | 1993-06-08 | 1994-12-20 | Fujisawa Pharmaceut Co Ltd | ローション剤 |
US5693648A (en) * | 1994-09-30 | 1997-12-02 | Merck & Co., Inc. | O-aryl, O-alkyl, O-alkenyl and O-alkynyl-macrolides having immunosuppressive activity |
CN1089233C (zh) | 1994-10-26 | 2002-08-21 | 诺瓦蒂斯有限公司 | 药物组合物 |
GB9826656D0 (en) | 1998-12-03 | 1999-01-27 | Novartis Ag | Organic compounds |
AU2004210201B2 (en) * | 2003-02-06 | 2009-10-08 | Cipla Limited | Topical immunotherapy and compositions for use therein |
US7186518B2 (en) * | 2003-11-21 | 2007-03-06 | Dade Behring Inc. | Method and composition useful for determining FK 506 |
WO2010041684A1 (ja) | 2008-10-08 | 2010-04-15 | 高田製薬株式会社 | タクロリムス外用剤 |
EP2308468A1 (en) * | 2009-10-08 | 2011-04-13 | Novaliq GmbH | Novel pharmaceutical composition comprising a macrolide immunosuppressant drug |
CN106074367A (zh) * | 2016-07-20 | 2016-11-09 | 中山大学中山眼科中心 | 含fk506类化合物/fkbp蛋白二聚体的药物组合物及其制备方法 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4139563A (en) * | 1977-07-01 | 1979-02-13 | Merrell Toraude Et Compagnie | α-ACETYLENIC DERIVATIVES OF AMINES |
ATE2269T1 (de) * | 1978-12-21 | 1983-02-15 | Gruppo Lepetit S.P.A. | 3h-naphtho(1,2-d)imidazole, verfahren zu deren herstellung, verbindungen zur verwendung als entzuendungshemmende und antimikrobielle mittel und sie enthaltende zusammensetzungen zu dieser verwendung. |
US4411893A (en) * | 1981-08-14 | 1983-10-25 | Minnesota Mining And Manufacturing Company | Topical medicament preparations |
US4556654A (en) * | 1983-06-28 | 1985-12-03 | Warner-Lambert Company | Antimicrobial substituted anthra[1,9-cd]pyrazol-6(2H)-ones |
US4894366A (en) * | 1984-12-03 | 1990-01-16 | Fujisawa Pharmaceutical Company, Ltd. | Tricyclo compounds, a process for their production and a pharmaceutical composition containing the same |
CA1272953A (en) * | 1984-10-08 | 1990-08-21 | Yuji Makino | Pharmaceutical composition for external use containing active-type vitamin d.sub.3 |
-
1988
- 1988-11-07 DK DK198806203A patent/DK175235B1/da not_active IP Right Cessation
- 1988-11-07 CH CH4131/88A patent/CH677448A5/de not_active IP Right Cessation
- 1988-11-07 PH PH37779A patent/PH26083A/en unknown
- 1988-11-07 GB GB8826066A patent/GB2212061B/en not_active Expired - Lifetime
- 1988-11-08 AU AU24902/88A patent/AU619772B2/en not_active Expired
- 1988-11-08 NL NL8802734A patent/NL195077C/nl not_active IP Right Cessation
- 1988-11-08 JP JP63283524A patent/JP2604834B2/ja not_active Expired - Lifetime
- 1988-11-08 SE SE8804036A patent/SE503236C2/sv unknown
- 1988-11-08 KR KR1019880014649A patent/KR0133916B1/ko not_active IP Right Cessation
- 1988-11-09 EP EP93120261A patent/EP0596541B1/en not_active Expired - Lifetime
- 1988-11-09 EP EP88118669A patent/EP0315978B1/en not_active Expired - Lifetime
-
1994
- 1994-01-21 HK HK86/94A patent/HK8694A/xx not_active IP Right Cessation
- 1994-05-06 CY CY173094A patent/CY1730A/xx unknown
- 1994-07-22 SE SE9402558A patent/SE519137C2/sv unknown
-
2004
- 2004-09-24 US US10/948,188 patent/US20050059694A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
SE8804036L (sv) | 1989-05-10 |
GB2212061B (en) | 1991-08-28 |
DK175235B1 (da) | 2004-07-19 |
EP0315978A3 (en) | 1990-06-13 |
SE9402558D0 (sv) | 1994-07-22 |
GB2212061A (en) | 1989-07-19 |
PH26083A (en) | 1992-02-06 |
KR0133916B1 (ko) | 1998-04-22 |
EP0596541A1 (en) | 1994-05-11 |
DK620388A (da) | 1989-05-10 |
NL8802734A (nl) | 1989-06-01 |
SE519137C2 (sv) | 2003-01-21 |
DK620388D0 (da) | 1988-11-07 |
CH677448A5 (sv) | 1991-05-31 |
US20050059694A1 (en) | 2005-03-17 |
EP0315978A2 (en) | 1989-05-17 |
KR890007736A (ko) | 1989-07-05 |
JP2604834B2 (ja) | 1997-04-30 |
GB8826066D0 (en) | 1988-12-14 |
HK8694A (en) | 1994-02-04 |
SE8804036D0 (sv) | 1988-11-08 |
SE503236C2 (sv) | 1996-04-22 |
EP0315978B1 (en) | 1994-10-26 |
EP0596541B1 (en) | 2000-03-15 |
AU2490288A (en) | 1989-05-11 |
JPH01157913A (ja) | 1989-06-21 |
NL195077C (nl) | 2003-07-23 |
AU619772B2 (en) | 1992-02-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1730A (en) | Topical compositions comprising 11,28-dioxa-4-azatricyclo(22.3.1.0(4,9)) octacos-18-ene derivatives | |
AU8065587A (en) | 3,4-dihydro-3-phenyl-2H-1-benzopyran derivatives | |
AU565087B2 (en) | 1,4-dihydro-4-oxonaphthyridine derivatives | |
AU7368187A (en) | 1,2,3,6-tetrahydro-5-nitro-pyrimidine derivatives | |
AU570667B2 (en) | 2-phenyl-3-oxo-3,4-dihydro-benzothiazine(1,4) derivatives | |
AU2948189A (en) | 4-aralkyl-5-substituted-1,2,4-triazole-5-thiols | |
AU1959488A (en) | (n-alpha-acyl, 8-glycine, des-19-leucine)-calcitonin | |
AU585373B2 (en) | 9-(substituted)phenyl-8,10-dioxo-4,1,7,9-thiatriazabicyclo (5.3.0)-decane-4-4-dioxide derivatives | |
PH25616A (en) | 1,2,3,4-tetrahydro-5-nitro-pyrimidine derivatives | |
AU574606B1 (en) | 1,5-diphenyl-1h-1,2,4-triazole-3-carboxamide derivatives | |
AU574211B2 (en) | 16-phenoxy 17,18,19,20, tetranorprosta 4,5,13,(e) trienoates | |
EP0316843A3 (en) | 1,2,3,4-tetrahydro-5-nitropyrimidine derivatives | |
IL75675A0 (en) | Antibacterial 7-oxo-4-thia-1-aza-bicyclo(3,2,0)hept-2-ene derivatives | |
ZA8784B (en) | 1,6-anhydro-beta-hexopyranose derivatives | |
IL83679A0 (en) | 2,4,6-trihydroxy-s-triazine derivatives | |
AU1072888A (en) | 3-aryl-5-alkylthio-4H-1,2,4-thiazoles | |
AU7519987A (en) | 1,1,2-triaryl-1-alkene derivatives | |
AU2169188A (en) | (2,3-anhydro-lyxofuranosyl) nucleosides | |
AU4387785A (en) | Benzo (c) (1,8) napthyridines | |
IL76328A0 (en) | 7-oxo-4-thia-1-azabicyclo(3,2,0)hept-2-ene derivatives | |
AU4023085A (en) | 1,2,4-triazacycloalkadiene derivatives | |
AU4417985A (en) | 4h-pyrimido (2,1a) isoquinolin -4-one derivatives | |
AU572645B2 (en) | Pyrido-(3,4-b) (1,4)-benzothiazine derivatives | |
AU2823089A (en) | 2,4- diaminoquinazoline derivatives | |
JPS6434951A (en) | Vermicide based on 2,3-diaminomaleonitrile derivative |